Salud financiera de hoja de balance de Patrys

Salud financiera controles de criterios 6/6

Patrys tiene un patrimonio de los accionistas total de A$5.0M y una deuda total de A$0.0, lo que sitúa su ratio deuda-patrimonio en 0%. Sus activos y pasivos totales son A$5.6M y A$584.2K respectivamente.

Información clave

Ratio deuda-patrimonio

AU$0

Deuda

Ratio de cobertura de intereses	n/a
Efectivo	AU$4.46m
Patrimonio	AU$5.02m
Total pasivo	AU$584.23k
Activos totales	AU$5.60m

Actualizaciones recientes sobre salud financiera

Recent updates

Here's Why It's Unlikely That Patrys Limited's (ASX:PAB) CEO Will See A Pay Rise This Year

Nov 08

Is Patrys (ASX:PAB) In A Good Position To Invest In Growth?

Mar 24

Here's Why Some Shareholders May Not Be Too Generous With Patrys Limited's (ASX:PAB) CEO Compensation This Year

Nov 09

Will Patrys (ASX:PAB) Spend Its Cash Wisely?

Sep 01

Is Patrys (ASX:PAB) In A Good Position To Invest In Growth?

May 11

We're Not Very Worried About Patrys' (ASX:PAB) Cash Burn Rate

Sep 28

We're Hopeful That Patrys (ASX:PAB) Will Use Its Cash Wisely

Jun 15

Companies Like Patrys (ASX:PAB) Are In A Position To Invest In Growth

Mar 01

What Can We Make Of Patrys' (ASX:PAB) CEO Compensation?

Jan 07

Análisis de la situación financiera

Pasivos a corto plazo: Los activos a corto plazo (A$5.2M) de PAB superan a sus pasivos a corto plazo (A$584.2K).

Pasivo a largo plazo: PAB no tiene pasivos a largo plazo.

Historial y análisis de deuda-patrimonio

Nivel de deuda: PAB está libre de deudas.

Reducción de la deuda: PAB no ha tenido ninguna deuda en los últimos 5 años.

Hoja de balance

Análisis de cash runway

En el caso de las empresas que de media han sido deficitarias en el pasado, evaluamos si tienen al menos 1 año de cash runway.

Cash runway estable: PAB tiene suficiente cash runway para más de 3 años basándose en su flujo de caja libre actual.

Pronóstico de cash runway: PAB dispone de suficiente cash runway para 1.9 años si el flujo de caja libre sigue reduciéndose a tasas históricas de 28.1% cada año.

Salud financiera de hoja de balance de Patrys

Salud financiera controles de criterios 6/6

Información clave

Actualizaciones recientes sobre salud financiera

Is Patrys (ASX:PAB) In A Good Position To Invest In Growth?

Patrys Limited, Melbourne Ordinary Shares to Be Deleted from OTC Equity

Will Patrys (ASX:PAB) Spend Its Cash Wisely?

Is Patrys (ASX:PAB) In A Good Position To Invest In Growth?

We're Not Very Worried About Patrys' (ASX:PAB) Cash Burn Rate

We're Hopeful That Patrys (ASX:PAB) Will Use Its Cash Wisely

Recent updates

New major risk - Market cap size

New major risk - Share price stability

New major risk - Market cap size

New major risk - Market cap size

Here's Why It's Unlikely That Patrys Limited's (ASX:PAB) CEO Will See A Pay Rise This Year

Patrys Limited Announces Retirement of Suzy Jones as Director

Full year 2023 earnings released: AU$0.003 loss per share (vs AU$0.003 loss in FY 2022)

Patrys Limited, Annual General Meeting, Nov 15, 2023

New minor risk - Financial data availability

Is Patrys (ASX:PAB) In A Good Position To Invest In Growth?

First half 2023 earnings released: AU$0.002 loss per share (vs AU$0.002 loss in 1H 2022)

Patrys Limited Appoints Charmaine Gittleson as the Chairman of the Board of Directors, Effective November 16, 2022

No independent directors

Here's Why Some Shareholders May Not Be Too Generous With Patrys Limited's (ASX:PAB) CEO Compensation This Year

Patrys Limited Announces New Preclinical Data for its Full-Sized IgG Antibody, Pat-DX3

Patrys Limited, Melbourne Ordinary Shares to Be Deleted from OTC Equity

Will Patrys (ASX:PAB) Spend Its Cash Wisely?

Patrys Limited Announces Appointment of Mr. Stefan Ross as Non-Executive Director

Full year 2022 earnings released: AU$0.003 loss per share (vs AU$0.003 loss in FY 2021)

Patrys Limited Announces Update on PAT-DX1 From Engineering Run Meets all Specification Tests

Patrys Limited Announces New Pre-Clinical Data for Its Lead Asset, Pat-Dx1

Patrys Limited Announces Successful Completion of Pat-Dx1 Engineering Run

Is Patrys (ASX:PAB) In A Good Position To Invest In Growth?

No independent directors

We're Not Very Worried About Patrys' (ASX:PAB) Cash Burn Rate

MD, CEO & Executive Director exercised options to buy AU$360k worth of stock.

Full year 2021 earnings released: AU$0.003 loss per share (vs AU$0.003 loss in FY 2020)

Patrys Limited Provides This Interim Update on Its PAT-DX1 Clinical Trial Program

Patrys Limited Announces Full Size Deoxymab PAT-DX3 Able to Cross the Blood Brain Barrier

Patrys Limited Announces the Publication of New Preclinical Data for Its Deoxymab Antibody PAT-DX1

We're Hopeful That Patrys (ASX:PAB) Will Use Its Cash Wisely

Companies Like Patrys (ASX:PAB) Are In A Position To Invest In Growth

First half 2021 earnings released: AU$0.001 loss per share (vs AU$0.002 loss in 1H 2020)

Patrys Limited Successfully Establishes PAT-DX1 Stable Cell Line

What Can We Make Of Patrys' (ASX:PAB) CEO Compensation?

Patrys Limited Adds Full Human Antibody to Deoxymab Portfolio

Earnings released

Análisis de la situación financiera

Historial y análisis de deuda-patrimonio

Hoja de balance

Análisis de cash runway

Descubre empresas con salud financiera